Evidence map›Paper›PMID 30720753›Full record

ArticlePlants (Basel, Switzerland)2019

The Power of Genomic

Ludmila Khrustaleva, Majd Mardini, Natalia Kudryavtseva, Rada Alizhanova, Dmitry Romanov, Pavel Sokolov, Grigory Monakhos

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 18 citations in OpenAlex.

  1. Species of the SectionsInternational journal of molecular sciences · 2024
    Review
  2. Article
  3. Genome Dominance inFrontiers in plant science · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ludmila KhrustalevaCenter of Molecular Biotechnology, Russian State Agrarian University-Moscow Timiryazev Agricultural Academy, 49, Timiryazevskaya Str., 127550 Moscow, Russia. ludmila.khrustaleva19@gmail.com.
Majd MardiniCenter of Molecular Biotechnology, Russian State Agrarian University-Moscow Timiryazev Agricultural Academy, 49, Timiryazevskaya Str., 127550 Moscow, Russia. mr.majdmardini@gmail.com.
Natalia KudryavtsevaCenter of Molecular Biotechnology, Russian State Agrarian University-Moscow Timiryazev Agricultural Academy, 49, Timiryazevskaya Str., 127550 Moscow, Russia. natalia.kudryavtseva92@gmail.com.
Rada AlizhanovaCenter of Molecular Biotechnology, Russian State Agrarian University-Moscow Timiryazev Agricultural Academy, 49, Timiryazevskaya Str., 127550 Moscow, Russia. rada.aliz@mail.ru.
Dmitry RomanovCenter of Molecular Biotechnology, Russian State Agrarian University-Moscow Timiryazev Agricultural Academy, 49, Timiryazevskaya Str., 127550 Moscow, Russia. akabos1987@gmail.com.
Pavel SokolovCenter of Molecular Biotechnology, Russian State Agrarian University-Moscow Timiryazev Agricultural Academy, 49, Timiryazevskaya Str., 127550 Moscow, Russia. pav2395147@yandex.ru.
Grigory MonakhosCenter of Molecular Biotechnology, Russian State Agrarian University-Moscow Timiryazev Agricultural Academy, 49, Timiryazevskaya Str., 127550 Moscow, Russia. breedst@mail.ru.
Russian State Agrarian University - Moscow Timiryazev Agricultural Academy · RU

Funding

Russian Science Foundation 16-16-10031
6 · The paper itself

Abstract

We exploited the advantages of genomic in situ hybridization (GISH) to monitor the introgression process at the chromosome level using a simple and robust molecular marker in the interspecific breeding of bulb onion (

Indexed as

Allium cepaA. royleiDMR1 markerdowny mildew resistancegenomic in situ hybridization (GISH)lethal factor

Identifiers

PMID30720753
PMCPMC6410304
OpenAlexW2911260891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.